Snippet from the article:
Around 80 women suffering hair loss are being recruited to trial the drug Spironolactone. While there is some evidence the drug is effective in arresting the progress of female baldness, the trial will be the first in the world to provide medical proof of its efficacy. Half of the women will take a placebo; the rest will take the drug.
Read the full text — Drug trial to end bad hair days for bald women
In theory, Spironolactone is anti-androgenic and some doctors have been using it for years. Thus, if hair loss is from androgenic causes (such as male pattern baldness) the belief is that it may help… but women generally do not have androgenic alopecia (men do). The results from what has been reported so far in past literature has been “iffy”, and not enough to drive me to recommend this drug or others like it.
We’ll see what the test concludes.